- Home
- PULM vs CLNN Comparison
PULM vs CLNN Comparison
Compare PULM & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PULM
- CLNN
- Stock Information
- Founded
- PULM 2003
- CLNN 2012
- Country
- PULM United States
- CLNN United States
- Employees
- PULM N/A
- CLNN N/A
- Industry
- PULM Biotechnology: Pharmaceutical Preparations
- CLNN Biotechnology: Pharmaceutical Preparations
- Sector
- PULM Health Care
- CLNN Health Care
- Exchange
- PULM Nasdaq
- CLNN Nasdaq
- Market Cap
- PULM 30.9M
- CLNN 26.1M
- IPO Year
- PULM N/A
- CLNN N/A
- Fundamental
- Price
- PULM $6.31
- CLNN $3.00
- Analyst Decision
- PULM
- CLNN Strong Buy
- Analyst Count
- PULM 0
- CLNN 4
- Target Price
- PULM N/A
- CLNN $55.25
- AVG Volume (30 Days)
- PULM 19.7K
- CLNN 58.4K
- Earning Date
- PULM 05-09-2025
- CLNN 05-07-2025
- Dividend Yield
- PULM N/A
- CLNN N/A
- EPS Growth
- PULM N/A
- CLNN N/A
- EPS
- PULM N/A
- CLNN N/A
- Revenue
- PULM $7,806,000.00
- CLNN $342,000.00
- Revenue This Year
- PULM N/A
- CLNN N/A
- Revenue Next Year
- PULM $134.88
- CLNN $2,066.67
- P/E Ratio
- PULM N/A
- CLNN N/A
- Revenue Growth
- PULM 6.96
- CLNN N/A
- 52 Week Low
- PULM $1.72
- CLNN $2.57
- 52 Week High
- PULM $10.40
- CLNN $9.20
- Technical
- Relative Strength Index (RSI)
- PULM 49.72
- CLNN 38.44
- Support Level
- PULM $5.31
- CLNN $2.76
- Resistance Level
- PULM $6.07
- CLNN $3.18
- Average True Range (ATR)
- PULM 0.50
- CLNN 0.30
- MACD
- PULM 0.03
- CLNN 0.05
- Stochastic Oscillator
- PULM 63.59
- CLNN 67.19
About PULM Pulmatrix Inc.
Pulmatrix Inc is a clinical-stage biotechnology company. The company is focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory diseases and infections with significant unmet medical needs. Pulmatrix designs and develops inhaled therapeutic products based on its proprietary dry powder delivery technology, iSPERSE (inhaled Small Particles Easily Respirable and Emitted), which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The iSPERSE powders are engineered to be small, dense particles with dispersibility and delivery to airways.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.